Kong G - Search Results

1

Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.

Park JH, Lee JY, Shin DH, Jang KS, Kim HJ, Kong G. Park JH, et al. Among authors: kong g. Oncogene. 2011 Nov 10;30(45):4578-89. doi: 10.1038/onc.2011.174. Epub 2011 May 23. Oncogene. 2011. PMID: 21602890

2

Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts.

Chung H, Jung YM, Shin DH, Lee JY, Oh MY, Kim HJ, Jang KS, Jeon SJ, Son KH, Kong G. Chung H, et al. Among authors: kong g. Int J Cancer. 2008 Feb 15;122(4):816-22. doi: 10.1002/ijc.23182. Int J Cancer. 2008. PMID: 17957784

3

Mel-18 negatively regulates INK4a/ARF-independent cell cycle progression via Akt inactivation in breast cancer.

Lee JY, Jang KS, Shin DH, Oh MY, Kim HJ, Kim Y, Kong G. Lee JY, et al. Among authors: kong g. Cancer Res. 2008 Jun 1;68(11):4201-9. doi: 10.1158/0008-5472.CAN-07-2570. Cancer Res. 2008. PMID: 18519679 Free article.

4

The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer.

Oh M, Lee JY, Shin DH, Park JH, Oian T, Kim HJ, Cho SD, Oh SH, Min YK, Kong G. Oh M, et al. Among authors: kong g. Cancer Sci. 2011 Mar;102(3):597-604. doi: 10.1111/j.1349-7006.2010.01817.x. Epub 2011 Jan 10. Cancer Sci. 2011. PMID: 21205071 Free PMC article.

5

Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.

Won HY, Lee JY, Shin DH, Park JH, Nam JS, Kim HC, Kong G. Won HY, et al. Among authors: kong g. FASEB J. 2012 Dec;26(12):5002-13. doi: 10.1096/fj.12-209247. Epub 2012 Sep 5. FASEB J. 2012. PMID: 22954590

6

CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway.

Kim HY, Park JH, Won HY, Lee JY, Kong G. Kim HY, et al. Among authors: kong g. FASEB J. 2015 Jan;29(1):300-13. doi: 10.1096/fj.14-253997. Epub 2014 Oct 28. FASEB J. 2015. PMID: 25351982

7

MEL-18, a tumor suppressor for aggressive breast cancer.

Lee JY, Kong G. Lee JY, et al. Among authors: kong g. Oncotarget. 2015 Jun 30;6(18):15710-1. doi: 10.18632/oncotarget.4565. Oncotarget. 2015. PMID: 26158291 Free PMC article. No abstract available.

8

6-Mercaptopurine, an activator of Nur77, enhances transcriptional activity of HIF-1alpha resulting in new vessel formation.

Yoo YG, Na TY, Yang WK, Kim HJ, Lee IK, Kong G, Chung JH, Lee MO. Yoo YG, et al. Among authors: kong g. Oncogene. 2007 May 31;26(26):3823-34. doi: 10.1038/sj.onc.1210149. Epub 2006 Dec 4. Oncogene. 2007. PMID: 17146432

9

Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition.

Lee JY, Kang MB, Jang SH, Qian T, Kim HJ, Kim CH, Kim Y, Kong G. Lee JY, et al. Among authors: kong g. Oncogene. 2009 Feb 12;28(6):824-31. doi: 10.1038/onc.2008.451. Epub 2008 Dec 15. Oncogene. 2009. PMID: 19079342

10

Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex.

Qian T, Lee JY, Park JH, Kim HJ, Kong G. Qian T, et al. Among authors: kong g. Oncogene. 2010 Oct 28;29(43):5818-27. doi: 10.1038/onc.2010.317. Epub 2010 Aug 9. Oncogene. 2010. PMID: 20697353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,090 results

Search Page

Filters